| Sulang Rosado, MD | |
|
12 St Paul Dr Ste 207, Chambersburg, PA 17201-1035 | |
| (717) 217-6882 | |
| (717) 217-6883 |
| Full Name | Sulang Rosado |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 23 Years |
| Location | 12 St Paul Dr Ste 207, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063474864 | NPI | - | NPPES |
| 1559302 | Other | PA | GATEWAY |
| 25-1716306 | Other | PA | INTERGROUP |
| 1007307260034 | Other | PA | MEDICAID GROUP # |
| 273592000 | Medicaid | FL | |
| 531092 | Other | PA | HEALTH AMERICA |
| P00458410 | Other | PA | RAILROAD MEDICARE |
| RO1923147 | Other | PA | HIGHMARK BLUESHIELD |
| 2157766 | Other | PA | MAMSI |
| 1466979 | Other | PA | AETNA HMO |
| 25-1716306 | Other | PA | INFORMED |
| 201712 | Other | PA | UNISON |
| 25-1716306 | Other | PA | MULTIPLAN/PHCS |
| 25-1716306 | Other | PA | SOUTH CENTRAL PREFERRED |
| 50065190 | Other | PA | CAPITAL BLUECROSS |
| 5662562 | Other | PA | FIRST HEALTH |
| 7386741 | Other | PA | AETNA NON-HMO |
| G920-0062/KV77CU | Other | PA | CAREFIRST |
| 25-1716306 | Other | PA | HEALTHNET/TRICARE |
| 120420413 | Other | PA | DEPT OF LABOR |
| 867633 | Other | PA | MEDICARE GROUP # |
| MD423743 | Other | PA | LICENSE |
| 1017833300001 | Medicaid | PA | |
| 25-1716306 | Other | PA | DEVON |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | ME93807 (Florida) | Secondary |
| 207V00000X | Obstetrics & Gynecology | MD423743 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carlisle Regional Medical Center | Carlisle, PA | Hospital |
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Health Medical Services | 7618960493 | 942 |
News Archive
Now, a new study by researchers from Germany's Paul Ehrlich Institute and published on the preprint server bioRxiv in July 2020 describes a potential vaccine based on the measles vaccine, which elicits both an antibody response and cellular immunity against the virus. This also protects against the measles virus. This could be a significant weapon in the fight against these two threats.
Boston University researchers, in collaboration with Centers for Therapeutic Innovation at Pfizer Inc., have discovered a novel molecular pathway needed to regulate kidney podocytes-special octopus-like cells that are critical in maintaining normal kidney function.
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., has launched an authorized generic version of Caduet in the U.S. market, as part of an agreement with Pfizer Inc.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
› Verified 3 days ago
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
Now, a new study by researchers from Germany's Paul Ehrlich Institute and published on the preprint server bioRxiv in July 2020 describes a potential vaccine based on the measles vaccine, which elicits both an antibody response and cellular immunity against the virus. This also protects against the measles virus. This could be a significant weapon in the fight against these two threats.
Boston University researchers, in collaboration with Centers for Therapeutic Innovation at Pfizer Inc., have discovered a novel molecular pathway needed to regulate kidney podocytes-special octopus-like cells that are critical in maintaining normal kidney function.
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., has launched an authorized generic version of Caduet in the U.S. market, as part of an agreement with Pfizer Inc.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sulang Rosado, MD 785 5th Avenue, Suite 3, Chambersburg, PA 17201-4232 Ph: (717) 263-9555 | Sulang Rosado, MD 12 St Paul Dr Ste 207, Chambersburg, PA 17201-1035 Ph: (717) 217-6882 |
News Archive
Now, a new study by researchers from Germany's Paul Ehrlich Institute and published on the preprint server bioRxiv in July 2020 describes a potential vaccine based on the measles vaccine, which elicits both an antibody response and cellular immunity against the virus. This also protects against the measles virus. This could be a significant weapon in the fight against these two threats.
Boston University researchers, in collaboration with Centers for Therapeutic Innovation at Pfizer Inc., have discovered a novel molecular pathway needed to regulate kidney podocytes-special octopus-like cells that are critical in maintaining normal kidney function.
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Ltd., has launched an authorized generic version of Caduet in the U.S. market, as part of an agreement with Pfizer Inc.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
› Verified 3 days ago
Dr. Joseph W Meyn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 120 N 7th St Ste 200, Chambersburg, PA 17201 Phone: 717-217-6882 Fax: 717-255-0157 | |
Dr. Marielle Sophia Gross, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 St Paul Dr, Chambersburg, PA 17201 Phone: 717-217-6882 Fax: 717-255-0157 | |
Dr. Sohael M Raschid, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1124 Kennebec Drive, Chambersburg, PA 17201 Phone: 717-263-8919 Fax: 717-263-2655 | |
Yvette Michelle Brown, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 5th Ave, Suite 202, Chambersburg, PA 17201 Phone: 717-217-6830 Fax: 717-217-6915 | |
Constance I Glass, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 St Paul Dr Ste 207, Chambersburg, PA 17201 Phone: 717-217-6882 Fax: 717-217-6883 | |
Dr. Branson Hunter Allen, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 12 St. Paul Drive, Wellspan Ob/gyn, Chambersburg, PA 17201 Phone: 717-217-6882 |